SCHEMBL2169720

SCHEMBL2169720

COc1ccc(Oc2ccc(CCC(N)=O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F2RL1 P55085 1/20 0.62
PARP10 Q53GL7 1/20 0.56
FFAR1 O14842 4/20 0.54
ALDH1A1 P00352 2/20 0.54
POLB P06746 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
SLC5A1 P13866 1/20 0.53
SLC5A2 P31639 1/20 0.53
TAAR1 Q96RJ0 1/20 0.52
ALOX5 P09917 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
MAPT P10636 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1413843 0.95 F2RL1 (0.68) F2RL1FFAR1ALDH1A1POLBNFKB1
SCHEMBL11904891 0.90 F2RL1 (0.62) F2RL1FFAR1ALDH1A1POLBNFKB1
SCHEMBL2172243 0.86 FFAR1 (0.53) F2RL1PARP10FFAR1ALDH1A1MAPT
SCHEMBL659052 0.86 ALOX5 (0.68) F2RL1ALDH1A1POLBTAAR1ALOX5
SCHEMBL2173032 0.84 FFAR1 (0.74) PARP10FFAR1SMN1; SMN2
SCHEMBL20019549 0.84 ALOX5 (0.61) F2RL1POLBTAAR1ALOX5
SCHEMBL13522667 0.83 ALOX5 (0.59) F2RL1POLBTAAR1ALOX5
SCHEMBL933946 0.83 ALOX5 (0.59) F2RL1POLBTAAR1ALOX5
SCHEMBL2170992 0.83 FFAR1 (0.53) PARP10FFAR1SLC5A1SLC5A2
SCHEMBL2171661 0.83 FFAR1 (0.53) FFAR1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed